• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FOXP3+ 调节性 T 细胞与实体瘤的免疫逃逸。

FOXP3+ regulatory T cells and the immune escape in solid tumours.

机构信息

Department of Breast Surgery, Obstetrics and Gynecology Hospital, Fudan University School of Medicine, Shanghai, China.

Center for Immune-Related Diseases at Shanghai Institute of Immunology, Department of Respiratory and Critical Care Medicine of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

出版信息

Front Immunol. 2022 Oct 13;13:982986. doi: 10.3389/fimmu.2022.982986. eCollection 2022.

DOI:10.3389/fimmu.2022.982986
PMID:36569832
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9774953/
Abstract

FOXP3+ regulatory T (Treg) cells play critical roles in establishing the immunosuppressive tumour microenvironment, which is achieved and dynamically maintained with the contribution of various stromal and immune cell subsets. However, the dynamics of non-lymphoid FOXP3+ Treg cells and the mutual regulation of Treg cells and other cell types in solid tumour microenvironment remains largely unclear. In this review, we summarize the latest findings on the dynamic connections and reciprocal regulations of non-lymphoid Treg cell subsets in accordance with well-established and new emerging hallmarks of cancer, especially on the immune escape of tumour cells in solid tumours. Our comprehension of the interplay between FOXP3+ Treg cells and key hallmarks of cancer may provide new insights into the development of next-generation engineered T cell-based immune treatments for solid tumours.

摘要

FOXP3+ 调节性 T(Treg)细胞在建立免疫抑制性肿瘤微环境中发挥着关键作用,这一过程是通过各种基质和免疫细胞亚群的贡献来实现和动态维持的。然而,非淋巴源性 FOXP3+Treg 细胞的动态以及 Treg 细胞与实体瘤微环境中其他细胞类型的相互调节在很大程度上仍不清楚。在这篇综述中,我们总结了非淋巴源性 Treg 细胞亚群的动态联系和相互调节的最新发现,这些发现与癌症的既定和新出现的特征有关,特别是与实体瘤中肿瘤细胞的免疫逃逸有关。我们对 FOXP3+Treg 细胞与癌症关键特征之间相互作用的理解,可能为开发新一代基于工程 T 细胞的实体瘤免疫治疗提供新的思路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a4/9774953/64a6d788c957/fimmu-13-982986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a4/9774953/41e1a9ef3e89/fimmu-13-982986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a4/9774953/5dae9537dd8e/fimmu-13-982986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a4/9774953/64a6d788c957/fimmu-13-982986-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a4/9774953/41e1a9ef3e89/fimmu-13-982986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a4/9774953/5dae9537dd8e/fimmu-13-982986-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d3a4/9774953/64a6d788c957/fimmu-13-982986-g003.jpg

相似文献

1
FOXP3+ regulatory T cells and the immune escape in solid tumours.FOXP3+ 调节性 T 细胞与实体瘤的免疫逃逸。
Front Immunol. 2022 Oct 13;13:982986. doi: 10.3389/fimmu.2022.982986. eCollection 2022.
2
Providence of the CD25 KIR CD127 FOXP3 CD8 T-cell subset determines the dynamics of tumor immune surveillance.CD25 KIR CD127 FOXP3 CD8 T 细胞亚群的Providence 决定了肿瘤免疫监视的动态。
Immunol Cell Biol. 2018 Nov;96(10):1035-1048. doi: 10.1111/imcb.12166. Epub 2018 Aug 17.
3
Human FOXP3 and tumour microenvironment.人类FOXP3与肿瘤微环境
Immunology. 2023 Feb;168(2):248-255. doi: 10.1111/imm.13520. Epub 2022 Jul 6.
4
Suppressive IL-17AFoxp3 and ex-Th17 IL-17AFoxp3 T cells are a source of tumour-associated T cells.抑制性的 IL-17A+Foxp3+ 和前 Th17 细胞 IL-17A+Foxp3+T 细胞是肿瘤相关 T 细胞的来源。
Nat Commun. 2017 Mar 14;8:14649. doi: 10.1038/ncomms14649.
5
PTEN-deficient prostate cancer is associated with an immunosuppressive tumor microenvironment mediated by increased expression of IDO1 and infiltrating FoxP3+ T regulatory cells.PTEN 缺陷型前列腺癌与免疫抑制性肿瘤微环境相关,这种微环境是由 IDO1 的表达增加和浸润的 FoxP3+T 调节细胞介导的。
Prostate. 2019 Jun;79(9):969-979. doi: 10.1002/pros.23808. Epub 2019 Apr 18.
6
Higher densities of Foxp3 regulatory T cells are associated with better prognosis in triple-negative breast cancer.在三阴性乳腺癌中,Foxp3调节性T细胞的较高密度与较好的预后相关。
Breast Cancer Res Treat. 2017 May;163(1):21-35. doi: 10.1007/s10549-017-4161-4. Epub 2017 Feb 23.
7
Advances in Foxp3+ regulatory T cells (Foxp3+ Treg) and key factors in digestive malignancies.Foxp3+ 调节性 T 细胞(Foxp3+Treg)的研究进展及其在消化道恶性肿瘤中的关键作用。
Front Immunol. 2024 Jun 11;15:1404974. doi: 10.3389/fimmu.2024.1404974. eCollection 2024.
8
Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.表达纽约食管鳞状细胞癌 1 及其与 Foxp3 和吲哚胺 2,3-双加氧酶在非小细胞肺癌微环境中的关系。
HLA. 2019 Jul;94(1):39-48. doi: 10.1111/tan.13547. Epub 2019 Apr 30.
9
MEK inhibition prevents tumour-shed transforming growth factor-β-induced T-regulatory cell augmentation in tumour milieu.MEK 抑制可防止肿瘤微环境中肿瘤脱落转化生长因子-β诱导的调节性 T 细胞扩增。
Immunology. 2015 Apr;144(4):561-73. doi: 10.1111/imm.12397.
10
Remodeling of the tumor microenvironment via disrupting Blimp1 effector Treg activity augments response to anti-PD-1 blockade.通过破坏 Blimp1 效应性 Treg 活性重塑肿瘤微环境可增强对抗 PD-1 封锁的反应。
Mol Cancer. 2021 Nov 20;20(1):150. doi: 10.1186/s12943-021-01450-3.

引用本文的文献

1
Single-cell RNA sequencing reveals different cellular states in malignant cells and the tumor microenvironment in primary and metastatic ER-positive breast cancer.单细胞RNA测序揭示了原发性和转移性雌激素受体阳性乳腺癌中恶性细胞及肿瘤微环境的不同细胞状态。
NPJ Breast Cancer. 2025 Aug 26;11(1):95. doi: 10.1038/s41523-025-00808-w.
2
Alzheimer's Disease-Associated Amyloid Beta Precursor Protein Prevents Aging Stress-Induced Mitophagy and Fumarate Depletion to Improve Anti-Tumor Immunity.阿尔茨海默病相关淀粉样前体蛋白可预防衰老应激诱导的线粒体自噬和富马酸耗竭,从而改善抗肿瘤免疫。
Cancer Res. 2025 Aug 7. doi: 10.1158/0008-5472.CAN-24-4740.
3

本文引用的文献

1
Identification and functional analysis of heterogeneous FOXP3 Treg cell subpopulations in human pancreatic ductal adenocarcinoma.人胰腺导管腺癌中异质性FOXP3调节性T细胞亚群的鉴定与功能分析。
Sci Bull (Beijing). 2018 Aug 15;63(15):972-981. doi: 10.1016/j.scib.2018.05.028. Epub 2018 May 30.
2
Gallic acid induces T-helper-1-like T cells and strengthens immune checkpoint blockade efficacy.没食子酸诱导辅助性 T 细胞 1 样 T 细胞并增强免疫检查点阻断的疗效。
J Immunother Cancer. 2022 Jul;10(7). doi: 10.1136/jitc-2021-004037.
3
L-5-hydroxytryptophan promotes antitumor immunity by inhibiting PD-L1 inducible expression.
The Aging Microenvironment as a Determinant of Immune Exclusion and Metastatic Fate in Pancreatic Cancer.
衰老微环境作为胰腺癌免疫排斥和转移命运的决定因素
bioRxiv. 2025 May 10:2025.05.08.652966. doi: 10.1101/2025.05.08.652966.
4
Development of therapeutic cancer vaccines based on cancer immunity cycle.基于癌症免疫循环的治疗性癌症疫苗的开发。
Front Med. 2025 Jul 14. doi: 10.1007/s11684-025-1134-6.
5
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications.黑色素瘤与免疫细胞中的过氧化物酶体增殖物激活受体γ:对疾病发病机制及治疗意义的见解
Cells. 2025 Apr 2;14(7):534. doi: 10.3390/cells14070534.
6
IGF1R activates FOXP3-β-catenin signaling to promote breast cancer development.胰岛素样生长因子1受体(IGF1R)激活叉头框蛋白P3(FOXP3)-β-连环蛋白信号通路以促进乳腺癌发展。
Breast Cancer Res Treat. 2025 Jun;211(2):467-478. doi: 10.1007/s10549-025-07663-0. Epub 2025 Mar 7.
7
Circular RNAs: key players in tumor immune evasion.环状RNA:肿瘤免疫逃逸的关键参与者。
Mol Cell Biochem. 2025 Jun;480(6):3267-3295. doi: 10.1007/s11010-024-05186-8. Epub 2025 Jan 4.
8
Single-cell spatial mapping reveals alteration of cell type composition and tissue microenvironment during early colorectal cancer formation.单细胞空间图谱揭示了结直肠癌早期形成过程中细胞类型组成和组织微环境的改变。
bioRxiv. 2024 Nov 21:2024.11.20.622725. doi: 10.1101/2024.11.20.622725.
9
Biochemical investigation of FOXP3 genetic polymorphism and its association with biochemical parameters in pre-eclampsia patients.子痫前期患者中FOXP3基因多态性的生化研究及其与生化参数的关联
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr;398(4):4583-4592. doi: 10.1007/s00210-024-03580-z. Epub 2024 Nov 7.
10
Efficacy, safety, and biomarker analysis of TACE combined with lenvatinib plus sintilimab in unresectable hepatocellular carcinoma: a real-world study.经导管动脉化疗栓塞术(TACE)联合仑伐替尼和信迪利单抗治疗不可切除肝细胞癌的疗效、安全性和生物标志物分析:一项真实世界研究。
Cancer Immunol Immunother. 2024 Nov 5;74(1):13. doi: 10.1007/s00262-024-03857-5.
L-5-羟色氨酸通过抑制 PD-L1 诱导表达促进抗肿瘤免疫。
J Immunother Cancer. 2022 Jun;10(6). doi: 10.1136/jitc-2021-003957.
4
Extricating human tumour immune alterations from tissue inflammation.从组织炎症中提取人类肿瘤免疫改变。
Nature. 2022 May;605(7911):728-735. doi: 10.1038/s41586-022-04718-w. Epub 2022 May 11.
5
Targeting the gut and tumor microbiota in cancer.靶向癌症中的肠道和肿瘤微生物组。
Nat Med. 2022 Apr;28(4):690-703. doi: 10.1038/s41591-022-01779-2. Epub 2022 Apr 19.
6
The increased ratio of Treg/Th2 in promoting metastasis of hepatocellular carcinoma.调节性 T 细胞/Th2 比值升高促进肝癌转移。
Cir Cir. 2022;90(2):187-192. doi: 10.24875/CIRU.21000361.
7
CCR8-targeted specific depletion of clonally expanded Treg cells in tumor tissues evokes potent tumor immunity with long-lasting memory.CCR8 靶向的肿瘤组织中克隆扩增 Treg 细胞的特异性耗竭引发具有持久记忆的强烈肿瘤免疫。
Proc Natl Acad Sci U S A. 2022 Feb 15;119(7). doi: 10.1073/pnas.2114282119.
8
Mycobacterial infection aggravates Helicobacter pylori-induced gastric preneoplastic pathology by redirection of de novo induced Treg cells.分枝杆菌感染通过重定向新诱导的 Treg 细胞加重幽门螺杆菌诱导的胃前肿瘤病理。
Cell Rep. 2022 Feb 8;38(6):110359. doi: 10.1016/j.celrep.2022.110359.
9
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer.抗 CCR4 治疗可消耗调节性 T 细胞,并在晚期前列腺癌犬模型中引发临床活性。
J Immunother Cancer. 2022 Feb;10(2). doi: 10.1136/jitc-2021-003731.
10
Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.乳酸在高度糖酵解的肿瘤微环境中促进调节性 T 细胞中 PD-1 的表达。
Cancer Cell. 2022 Feb 14;40(2):201-218.e9. doi: 10.1016/j.ccell.2022.01.001. Epub 2022 Jan 28.